Diabetes medications with cardiovascular protection in the wake of EMPA-REG OUTCOME: the optimal combination may be metformin, pioglitazone and empagliflozin.
| Autor: | RYDER, ROBERT EJ, DEFRONZO, RALPH A, Ryder, Dr Bob |
|---|---|
| Zdroj: | British Journal of Diabetes & Vascular Disease; Oct-Dec2015, Vol. 15 Issue 4, p151-154, 4p |
| Databáze: | Complementary Index |
| Externí odkaz: |
|